Vizimpro – Dacomitinib uses, dose and side effects
Vizimpro contains the active substance dacomitinib, which belongs to a group of medicines called protein tyrosine kinase inhibitors used to treat cancer.
Read MoreVizimpro contains the active substance dacomitinib, which belongs to a group of medicines called protein tyrosine kinase inhibitors used to treat cancer.
Read More© 2022. All Rights Reserved